Similar Search Results

Management of Hypertension in Patients with Diabetes Mellitus: Defining the Role of Lisinopril

Jarvis, Blair; Spencer, Caroline M. - In: Disease Management and Health Outcomes 7 (2000) 5, pp. 267-288

Hypertension and diabetes mellitus are significant and independent risk factors for cardiovascular disease. Antihypertensive therapy reduces cerebrovascular and cardiovascular morbidity and mortality in patients with hypertension. Tight blood pressure (BP) control [target diastolic BP (DBP)...

Persistent link: https://www.econbiz.de/10005242987

Guidelines for General Practitioners: Approaches for Managing the Information Influx for Effective Disease Management

Pencheon, David - In: Disease Management and Health Outcomes 6 (1999) 2, pp. 59-63

The increasing speed at which new knowledge is generated and disseminated means that we have to learn knew ways of handling this information. Instead of trying to remember information in case we need it at a later date, we need to develop the skills of finding, appraising and using information...

Persistent link: https://www.econbiz.de/10005242988

Disease Management of Chronic Heart Failure in the Elderly: Issues and Options

McDonald, Ken - In: Disease Management and Health Outcomes 15 (2007) 6, pp. 333-339

There is now conclusive evidence to support the widely prescribed application of disease management programs in heart failure care. These strategies result in significant improvement in many barometers of care, including admission rates, prescription of disease modifying therapy, and improved...

Persistent link: https://www.econbiz.de/10005242989

The Emerging Role of the Consumer in Pharmaceutical Pricing Decisions

Chumney, Elinor C.; Simpson, Kit N. - In: Disease Management and Health Outcomes 10 (2002) 4, pp. 229-232

The absence of government regulation in the US has left pharmaceutical companies free to set their own prices based on a number of market considerations. Historically, these have included not only ingredient, research and development costs, but also advertising, the drug's marginal...

Persistent link: https://www.econbiz.de/10005242990

Physician Financial Incentives in Managed Care: Resource Use, Quality and Cost Implications

Armour, Brian S.; Pitts, Mmelinda - In: Disease Management and Health Outcomes 11 (2003) 3, pp. 139-147

Patients with health insurance do not make the most cost conscious healthcare decisions since they bear only a fraction of the total cost of medical care. Managed care advocates point to financial incentives as a way to reduce wasteful resource use. However, physicians with managed care...

Persistent link: https://www.econbiz.de/10005242991

Atypical Antipsychotics as First-Line Treatments for Schizophrenia: Advantages for Stakeholders in the UK Healthcare System

Mortimer, Ann M. - In: Disease Management and Health Outcomes 12 (2004) 3, pp. 169-179

The poor efficacy and tolerability of conventional antipsychotic treatment in schizophrenia, together with discovery of the

Persistent link: https://www.econbiz.de/10005242992

Sickle Cell Disease Screening Programs: Integration Into Managed Care

Davies, Sally C.; Oni, Lola - In: Disease Management and Health Outcomes 9 (2001) 6, pp. 295-304

of patient education and optimized clinical management. However, informed patient or parental consent is necessary prior …-screening information for clients available in an appropriate format, continuing education for health professionals, and effective post …-result education with specialist follow-up for those affected by sickle cell disease. Effective handling, storage and retrieval of …

Persistent link: https://www.econbiz.de/10005242993

Lessons from Early Experience with Pay for Performance

Doran, Tim - In: Disease Management and Health Outcomes 16 (2008) 2, pp. 69-77

Pay-for-performance schemes share the common approach of offering financial incentives to healthcare providers for achieving specified performance targets. Such schemes are becoming increasingly popular with healthcare policy makers and funders worldwide, despite a relative lack of evidence on...

Persistent link: https://www.econbiz.de/10005242994

Evaluation and Treatment of Depression (Part I): Benefits for Patients, Providers, and Payors

Kramer, Teresa L.; Beaudin, Christy L.; Thrush, Carol R. - In: Disease Management and Health Outcomes 13 (2005) 5, pp. 295-306

patient education, coordination of care between primary care and mental health specialists, and ongoing evaluation and …

Persistent link: https://www.econbiz.de/10005242995

This Month's News

Adis International Limited - In: Disease Management and Health Outcomes 9 (2001) 4, pp. 235-237

Persistent link: https://www.econbiz.de/10005242996

1
2
3
4
5
6
7
8
9
10
Next
Last